Philips partners with start-up DEARhealth DEARhealth — a health tech spin-out from the University of California, Los Angeles — announced a €6.0 million ($6.8 million) investment in Series A funding from Philips and other backers. DEARhealth aims to help providers and patients manage chronic conditions, such as inflammatory bowel disease, liver and kidney diseases, ovarian cancer and chronic pain. It strives to provide patient-centric, data-driven and AI-powered care pathways, orchestrating the work of everyone involved in providing care. The DEARhealth platform predicts the best care pathway with the lowest risks and seamlessly integrates these recommendations into existing EMRs. With the new funding, DEARhealth will be able to implement its technology in more hospitals and expand operations to Europe. “Hospitals will become software-powered organizations,” says Daniel Hommes, chief executive officer at DEARhealth. “DEAR is ready to support that transformation for chronic care.”
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.